Evidence map›Paper›PMID 22999959›Full record

ArticleFertility and sterility2013

Phospholipase Cζ rescues failed oocyte activation in a prototype of male factor infertility.

Michail Nomikos, Yuansong Yu, Khalil Elgmati, Maria Theodoridou, Karen Campbell, Vyronia Vassilakopoulou, Christos Zikos, Evangelia Livaniou, Nazar Amso, George Nounesis and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Fertility and sterility, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. High rate of detected variants in maleHuman reproduction open · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Artificial oocyte activation with CaFrontiers in endocrinology · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Michail NomikosCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom; National Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece. Electronic address: mixosn@yahoo.com.
Yuansong YuCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Khalil ElgmatiCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Maria TheodoridouCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom; National Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece.
Karen CampbellIVF Wales, University Hospital of Wales, Heath Park, Cardiff, United Kingdom.
Vyronia VassilakopoulouNational Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece.
Christos ZikosNational Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece.
Evangelia LivaniouNational Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece.
Nazar AmsoCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
George NounesisNational Center for Scientific Research "Demokritos," Aghia Paraskevi, Greece.
Karl SwannCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
F Anthony LaiCardiff University School of Medicine, Heath Park, Cardiff, United Kingdom. Electronic address: lait@cf.ac.uk.
National Centre of Scientific Research "Demokritos" · GRCardiff University · GBUniversity Hospital of Wales · GB

Funding

Wellcome TrustWellcome Trust 080701/Z/06/Z
6 · The paper itself

Abstract

objectiveTo determine the effect of infertility-linked sperm phospholipase Cζ (PLCζ) mutations on their ability to trigger oocyte Ca(2+) oscillations and development, and also to evaluate the potential therapeutic utility of wild-type, recombinant PLCζ protein for rescuing failed oocyte activation and embryo development.

designTest of a novel therapeutic approach to male factor infertility.

settingUniversity medical school research laboratory. PATIENT(S): Donated unfertilized human oocytes from follicle reduction. INTERVENTION(S): Microinjection of oocytes with recombinant human PLCζ protein or PLCζ cRNA and a Ca(2+)-sensitive fluorescent dye. MAIN OUTCOME MEASURE(S): Measurement of the efficacy of mutant and wild-type PLCζ-mediated enzyme activity, oocyte Ca(2+) oscillations, activation, and early embryo development. RESULT(S): In contrast to the wild-type protein, mutant forms of human sperm PLCζ display aberrant enzyme activity and a total failure to activate unfertilized oocytes. Subsequent microinjection of recombinant human PLCζ protein reliably triggers the characteristic pattern of cytoplasmic Ca(2+) oscillations at fertilization, which are required for normal oocyte activation and successful embryo development to the blastocyst stage. CONCLUSION(S): Dysfunctional sperm PLCζ cannot trigger oocyte activation and results in male factor infertility, so a potential therapeutic approach is oocyte microinjection of active, wild-type PLCζ protein. We have demonstrated that recombinant human PLCζ can phenotypically rescue failed activation in oocytes that express dysfunctional PLCζ, and that this intervention culminates in efficient blastocyst formation.

Indexed as

AnimalsCalciumCytoplasmEmbryonic DevelopmentFemaleHumansInfertility, MaleIn Vitro TechniquesMaleMiceMicroinjectionsModels, AnimalMutationOocytesPhosphoinositide Phospholipase CRecombinant ProteinsCalciumPhosphoinositide Phospholipase CPLCZ1 protein, humanRecombinant Proteins

Identifiers

PMID22999959
PMCPMC3540263
OpenAlexW1982784931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.